{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T16:26:29Z","timestamp":1745598389734},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10165-011-0529-1","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T19:53:11Z","timestamp":1316202791000},"page":"474-478","source":"Crossref","is-referenced-by-count":1,"title":["Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1\u03b1 for concomitant longstanding multiple sclerosis"],"prefix":"10.1093","volume":"22","author":[{"given":"Andreas P.","family":"Diamantopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atle E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geirmund","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,9,17]]},"reference":[{"issue":"8","key":"529_CR1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/kep153","volume":"48","author":"R Watts","year":"2009","unstructured":"Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009;48(8):1008\u201311.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"529_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.55.7.481","volume":"55","author":"SL Johnston","year":"2002","unstructured":"Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55(7):481\u20136.","journal-title":"J Clin Pathol"},{"issue":"7","key":"529_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrrheum.2010.82","volume":"6","author":"JC Mason","year":"2010","unstructured":"Mason JC. Takayasu arteritis\u2014advances in diagnosis and management. Nat Rev Rheumatol. 2010;6(7):406\u201315.","journal-title":"Nat Rev Rheumatol"},{"issue":"9313","key":"529_CR4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221\u201331.","journal-title":"Lancet"},{"issue":"2","key":"529_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2003-41138","volume":"23","author":"BC Kieseier","year":"2003","unstructured":"Kieseier BC, Hartung HP. Current disease-modifying therapies in multiple sclerosis. Semin Neurol. 2003;23(2):133\u201346.","journal-title":"Semin Neurol"},{"issue":"10","key":"529_CR6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jocn.2006.07.011","volume":"14","author":"T Gono","year":"2007","unstructured":"Gono T, Matsuda M, Shimojima Y, Kaneko K, Murata H, Ikeda S. Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient. J Clin Neurosci. 2007;14(10):997\u20131000.","journal-title":"J Clin Neurosci"},{"key":"529_CR7","doi-asserted-by":"crossref","unstructured":"Crispin JC, Diaz-Jouanen E. Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis. Lupus. 2005;14(6):495\u20136.","DOI":"10.1191\/0961203305lu2147xx"},{"issue":"10","key":"529_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1155\/2009\/651952","volume":"23","author":"N Mistry","year":"2009","unstructured":"Mistry N, Shapero J, Crawford RI. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol. 2009;23(10):677\u201383.","journal-title":"Can J Gastroenterol"},{"key":"529_CR9","doi-asserted-by":"crossref","unstructured":"Biggioggero M, Gabbriellini L, Meroni PL. Type 1 interferon therapy and its role in autoimmunity. Autoimmunity. 2010;43(3):248\u201354.","DOI":"10.3109\/08916930903510971"},{"issue":"8","key":"529_CR10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129\u201334.","journal-title":"Arthritis Rheum"},{"key":"529_CR11","doi-asserted-by":"crossref","unstructured":"Kalliolias GD, Ivashkiv LB. Overview of the biology of type I interferons. Arthritis Res Ther. 2010;12(Suppl 1):S1.","DOI":"10.1186\/ar2881"},{"issue":"12","key":"529_CR12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975\u201390.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"529_CR13","first-page":"565","volume":"71","author":"DL Brassard","year":"2002","unstructured":"Brassard DL, Grace MJ, Bordens RW. Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol. 2002;71(4):565\u201381.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"529_CR14","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","volume":"98","author":"C Manca","year":"2001","unstructured":"Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of INF-alpha\/beta. Proc Natl Acad Sci USA. 2001;98(10):5752\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"529_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0167-5699(99)01541-8","volume":"21","author":"CL Karp","year":"2000","unstructured":"Karp CL, Biron CA, Irani DN. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today. 2000;21(1):24\u20138.","journal-title":"Immunol Today"},{"issue":"1","key":"529_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/76940","volume":"1","author":"KB Nguyen","year":"2000","unstructured":"Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha\/beta-mediated inhibition and promotion of interferon gamma: Stat1 resolves a paradox. Nat Immunol. 2000;1(1):70\u20136.","journal-title":"Nat Immunol"},{"issue":"8","key":"529_CR17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930310001605882","volume":"36","author":"LB Ivashkiv","year":"2003","unstructured":"Ivashkiv LB. Type-I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity. 2003;36(8):473\u20139.","journal-title":"Autoimmunity"},{"key":"529_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"AN Theofilopoulos","year":"2005","unstructured":"Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type-I interferons (alpha\/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307\u201336.","journal-title":"Annu Rev Immunol"},{"key":"529_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2005.00252.x","volume":"204","author":"R Baccala","year":"2005","unstructured":"Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev. 2005;204:9\u201326.","journal-title":"Immunol Rev"},{"issue":"8","key":"529_CR20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/08916930310001605873","volume":"36","author":"C Gota","year":"2003","unstructured":"Gota C, Calabrese L. Induction of clinical autoimmune disease by therapeutic interferon-alpha. Autoimmunity. 2003;36(8):511\u20138.","journal-title":"Autoimmunity"},{"issue":"9","key":"529_CR21","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","volume":"99","author":"M Montoya","year":"2002","unstructured":"Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood. 2002;99(9):3263\u201371.","journal-title":"Blood"},{"key":"529_CR22","unstructured":"Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, et al. Type-I IFNs enhance the terminal differentiation of dendritic cells. J Immunol. 1998;161(4):1947\u201353."},{"issue":"10","key":"529_CR23","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","volume":"191","author":"SM Santini","year":"2000","unstructured":"Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, et al. Type-I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 2000;191(10):1777\u201388.","journal-title":"J Exp Med"},{"issue":"6","key":"529_CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","volume":"14","author":"CA Biron","year":"2001","unstructured":"Biron CA. Interferons alpha and beta as immune regulators\u2014a new look. Immunity. 2001;14(6):661\u20134.","journal-title":"Immunity"},{"issue":"2","key":"529_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133\u201346.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"529_CR26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","volume":"189","author":"P Marrack","year":"1999","unstructured":"Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med. 1999;189(3):521\u201330.","journal-title":"J Exp Med"},{"issue":"5","key":"529_CR27","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","volume":"178","author":"V Brinkmann","year":"1993","unstructured":"Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993;178(5):1655\u201363.","journal-title":"J Exp Med"},{"issue":"9","key":"529_CR28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.186.9.1495","volume":"186","author":"AI Sharara","year":"1997","unstructured":"Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA, Weinberg JB. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med. 1997;186(9):1495\u2013502.","journal-title":"J Exp Med"},{"issue":"2","key":"529_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","volume":"19","author":"G Jego","year":"2003","unstructured":"Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003;19(2):225\u201334.","journal-title":"Immunity"},{"issue":"8","key":"529_CR30","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","volume":"169","author":"KB Nguyen","year":"2002","unstructured":"Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol. 2002;169(8):4279\u201387.","journal-title":"J Immunol"},{"issue":"3","key":"529_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardiores.2005.03.013","volume":"66","author":"R Wessely","year":"2005","unstructured":"Wessely R. Interference by interferons: Janus faces in vascular proliferative diseases. Cardiovasc Res. 2005;66(3):433\u201343.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"529_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","volume":"199","author":"W Ma-Krupa","year":"2004","unstructured":"Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2004;199(2):173\u201383.","journal-title":"J Exp Med"},{"key":"529_CR33","doi-asserted-by":"crossref","unstructured":"Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, et al. Perforin-secreting killer cell infiltration and expression of a 65-kd heat-shock protein in aortic tissue of patients with Takayasu\u2019s arteritis. J Clin Invest. 1994;93(2):750\u20138.","DOI":"10.1172\/JCI117029"},{"issue":"6","key":"529_CR34","first-page":"1925","volume":"148","author":"AD Wagner","year":"1996","unstructured":"Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol. 1996;148(6):1925\u201333.","journal-title":"Am J Pathol"},{"issue":"2","key":"529_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349(2):160\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"529_CR36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/rheumatology\/kei266","volume":"45","author":"MC Park","year":"2006","unstructured":"Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu\u2019s arteritis. Rheumatology (Oxford). 2006;45(5):545\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"529_CR37","doi-asserted-by":"crossref","unstructured":"Wagner AD, Goronzy JJ, Weyand CM. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest. 1994;94(3):1134\u201340.","DOI":"10.1172\/JCI117428"},{"issue":"2","key":"529_CR38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.2004.02613.x","volume":"138","author":"NK Tripathy","year":"2004","unstructured":"Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu\u2019s arteritis. Clin Exp Immunol. 2004;138(2):369\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"529_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1568-9972(03)00064-8","volume":"3","author":"CM Weyand","year":"2004","unstructured":"Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3(1):46\u201353.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"529_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1536\/jhj.41.15","volume":"41","author":"Y Seko","year":"2000","unstructured":"Seko Y. Takayasu arteritis: insights into immunopathology. Jpn Heart J. 2000;41(1):15\u201326.","journal-title":"Jpn Heart J"},{"issue":"8","key":"529_CR41","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/art.22801","volume":"56","author":"SK Chauhan","year":"2007","unstructured":"Chauhan SK, Singh M, Nityanand S. Reactivity of gamma\/delta T cells to human 60-kd heat-shock protein and their cytotoxicity to aortic endothelial cells in Takayasu arteritis. Arthritis Rheum. 2007;56(8):2798\u2013802.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"529_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0967-2109(99)00100-3","volume":"8","author":"SJ Inder","year":"2000","unstructured":"Inder SJ, Bobryshev YV, Cherian SM, Wang AY, Lord RS, Masuda K, et al. Immunophenotypic analysis of the aortic wall in Takayasu\u2019s arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions. Cardiovasc Surg. 2000;8(2):141\u20138.","journal-title":"Cardiovasc Surg"},{"issue":"3","key":"529_CR43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.1780370323","volume":"37","author":"D Sima","year":"1994","unstructured":"Sima D, Thiele B, Turowski A, Wilke K, Hiepe F, Volk D, et al. Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum. 1994;37(3):441\u20133.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"529_CR44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/rheumatology\/36.8.923","volume":"36","author":"S Nityanand","year":"1997","unstructured":"Nityanand S, Mishra K, Shrivastava S, Holm G, Lefvert AK. Autoantibodies against cardiolipin and endothelial cells in Takayasu\u2019s arteritis: prevalence and isotype distribution. Br J Rheumatol. 1997;36(8):923\u20134.","journal-title":"Br J Rheumatol"},{"key":"529_CR45","unstructured":"Baltazares M, Mendoza F, Dabague J, Reyes PA. Antiaorta antibodies and Takayasu arteritis. Int J Cardiol. 1998;66(Suppl 1):S183\u20137. Discussion S189."},{"issue":"2","key":"529_CR46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2249.2003.02282.x","volume":"134","author":"NK Tripathy","year":"2003","unstructured":"Tripathy NK, Sinha N, Nityanand S. Anti-annexin V antibodies in Takayasu\u2019s arteritis: prevalence and relationship with disease activity. Clin Exp Immunol. 2003;134(2):360\u20134.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"529_CR47","first-page":"2023","volume":"30","author":"NK Tripathy","year":"2003","unstructured":"Tripathy NK, Sinha N, Nityanand S. Antimonocyte antibodies in Takayasu\u2019s arteritis: prevalence of and relation to disease activity. J Rheumatol. 2003;30(9):2023\u20136.","journal-title":"J Rheumatol"},{"issue":"7","key":"529_CR48","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/art.21921","volume":"54","author":"SK Chauhan","year":"2006","unstructured":"Chauhan SK, Tripathy NK, Nityanand S. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum. 2006;54(7):2326\u201333.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"529_CR49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.2004.02644.x","volume":"138","author":"S Kumar Chauhan","year":"2004","unstructured":"Kumar Chauhan S, Kumar Tripathy N, Sinha N, Singh M, Nityanand S. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu\u2019s arteritis. Clin Exp Immunol. 2004;138(3):547\u201353.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"529_CR50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e32833ee946","volume":"23","author":"CM Weyand","year":"2011","unstructured":"Weyand CM, Younge BR, Goronzy JJ. IFN-gamma and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol. 2011;23(1):43\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"529_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/BOR.0b013e3280119866","volume":"19","author":"Y Seko","year":"2007","unstructured":"Seko Y. Giant cell and Takayasu arteritis. Curr Opin Rheumatol. 2007;19(1):39\u201343.","journal-title":"Curr Opin Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0529-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:37Z","timestamp":1646843137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0529-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,17]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0529-1","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,17]]}}}